SynthesisFrontiers in immunology2026
The efficacy and safety of disitamab vedotin plus immunotherapy in locally advanced or metastatic solid tumors: a systematic review and meta-analysis.
Jianjun Ye et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.